| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.52 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |